SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-14-069527
Filing Date
2014-10-01
Accepted
2014-10-01 17:02:51
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 a14-21683_1s3.htm S-3 483738
2 EX-4.1 a14-21683_1ex4d1.htm EX-4.1 835293
3 EX-4.2 a14-21683_1ex4d2.htm EX-4.2 900651
4 EX-5.1 a14-21683_1ex5d1.htm EX-5.1 16960
5 EX-23.1 a14-21683_1ex23d1.htm EX-23.1 3410
6 GRAPHIC g216831bqi001.jpg GRAPHIC 16854
7 GRAPHIC g216831bci001.jpg GRAPHIC 16854
  Complete submission text file 0001104659-14-069527.txt   2287778
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: S-3 | Act: 33 | File No.: 333-199107 | Film No.: 141133754
SIC: 2836 Biological Products, (No Diagnostic Substances)